Computer program improves neuromuscular blockade quality, safety
MedWire News: Use a computer control program for neuromuscular blockade dosing markedly improves the quality of blockade during surgery and raises postoperative train-of-four ratios, shows a preliminary study.
“We believe that this technology has the potential to greatly enhance patient safety,” say Stephan Schwarz (University of British Columbia, Vancouver, Canada) and colleagues.
The Neuromuscular Blockade Advisory System (NMBAS) is an adaptive computer control program that advises the anesthesiologist on the timing and dose of neuromuscular blockade drugs.
Its recommendations are generated from a model (sixth-order Laguerre model) based on published pharmacokinetic–pharmacodynamic parameters, and are modified by the patient’s electromyographic responses to train-of-four stimulation.
Schwarz and team assessed 60 patients undergoing surgery lasting more than 1.5 hours who were randomly assigned to undergo neuromuscular blockade with or without the NMBAS.
They report in the journal Anesthesia & Analgesia that just eight of 30 patients assigned to the NMBAS had intra-operative events that indicated inadequate neuromuscular blockade, compared with 19 of 30 controls.
Such events included inadequate surgical relaxation, patient motion (as judged by the surgeon), breathing against the ventilator, and bucking or coughing on the ventilator.
Furthermore, the average train-of-four ratio after surgery was 0.59 in the NMBAS group, compared with just 0.14 in the control group.
“Anesthesiologists' compliance on the whole with the NMBAS and its recommendations was high, which provides an indication of the system's overall clinical applicability and utility,” the researchers note.
They observe that the design of the NMBAS can be adapted for control of other patient parameters, such as depth of anesthesia, blood pressure, and dysrhythmias.
“Therefore, the NMBAS’ Laguerre-based adaptive control technology represents a general platform from which to develop other automatic drug delivery systems for the operating room, intensive care unit, or, eventually, ambulatory use,” the team concludes.
Bookmarks